Shareholders that held Pfizer common stock as of the close of business on November 13, 2020, the record date, and did not sell their rights to receive Viatris common stock before the close of business on November 16, 2020, received approximately 0.124079 of a share of Viatris common stock for every share of Pfizer …
Does Pfizer own Viatris?
Pfizer recently completed a spin-off of it’s Upjohn business, combining it with Mylan N.V. to form a new entity, Viatris, which began trading on 11/16/2020 under the ticker symbol VTRS.
Will PFE shareholders get Viatris stock?
In the distribution, Pfizer stockholders received approximately 0.124079 shares of Viatris common stock for every one share of Pfizer common stock held as of the close of business on the record date (which was November 13, 2020). … Viatris (Nasdaq: VTRS) will begin trading tomorrow, November 17, 2020.
Will Viatris have a dividend?
A cash dividend payment of $0.11 per share is scheduled to be paid on June 16, 2021. Shareholders who purchased VTRS prior to the ex-dividend date are eligible for the cash dividend payment. At the current stock price of $15.5, the dividend yield is 2.84%.
Does VTRS pay a dividend?
VTRS pays a dividend of $0.11 per share. VTRS’s annual dividend yield is 0.76%. Viatris’s dividend is lower than the US Drug Manufacturers – Specialty & Generic industry average of 1.82%, and it is lower than the US market average of 3.27%.
Why did I get shares of Viatris?
That’s because Viatris was formed through the merger of Mylan and Upjohn, the generics unit of Pfizer (NYSE:PFE). Pfizer shareholders were given a little more than 12 shares in Viatris for every 100 they held in Pfizer. Mylan shareholders got a Viatris share for every previous Mylan share they held.
Is Viatris a good stock to buy?
In other words, based on forward earnings, Viatris stock looks like an incredibly good value, and not only that, the company has promised to pay an annual dividend of 25% of free cash flow, which based on guidance for $2.15bn in FY21 at the midpoint, works out at $540m, or $0.11 per share – an annualised yield of ~3% …
What companies has Pfizer bought?
Following the news that the American giant is buying cancer drug company Medivation for $14 billion, here are some of Pfizer’s most expensive deals to date:
- King Pharmaceuticals, $3.6 billion. Pfizer acquired King Pharmaceuticals in 2010.
- Hospira, $15.2 billion. …
- Wyeth, $68 billion. …
- Warner-Lambert, $90.2.
When was the last Pfizer stock split?
PFE’s third split took place on July 03, 1995. This was a 2 for 1 split, meaning for each share of PFE owned pre-split, the shareholder now owned 2 shares.
|PFE Split History Table|
|07/01/1999||3 for 1|
|11/17/2020||1054 for 1000|
Is Viatris a buy or sell?
Currently, Viatris trades at a forward P/E of just 4.2, making it one of the cheapest stocks on the market today. The consensus among analysts on Wall Street is that the stock will rise by 50% over the next year.
What stock pays the highest dividend?
25 Top-Paying Dividend Stocks That Will Make You Rich
- Franklin Resources. …
- Walgreens Boots Alliance. …
- AbbVie Inc. …
- Federal Realty Investment Trust. …
- People’s United Financial. Annual dividend: $0.72. …
- Chevron Corp. Annual dividend: $5.16. …
- AT&T Inc. Annual dividend: $2.08. …
- Exxon Mobil Corp. Annual dividend: $3.48.
Is Pfizer a good dividend stock?
Even with a lower payout, Pfizer’s dividend will remain quite attractive. The company has strong growth prospects, particularly with its successful COVID-19 vaccine. The stock is also relatively cheap, with shares trading at around 11.4 times expected earnings.